Odonate Therapeutics Probability of Future Stock Price Finishing Over 0.0

Odonate Therapeutics' future price is the expected price of Odonate Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Odonate Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
  
Please specify Odonate Therapeutics' target price for which you would like Odonate Therapeutics odds to be computed.

Odonate Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Odonate Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Odonate Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Odonate Therapeutics is not yet fully synchronised with the market data
Odonate Therapeutics has some characteristics of a very speculative penny stock
Odonate Therapeutics has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (102.07 M).
Odonate Therapeutics has about 95.03 M in cash with (94.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Roughly 66.0% of the company shares are owned by institutional investors

Odonate Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Odonate Stock often depends not only on the future outlook of the current and potential Odonate Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Odonate Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.54%
Short Percent Of Float3.59%
Float Shares20.63M
Shares Short Prior Month277.45k
Average Daily Volume Last 10 Day527.64k
Average Daily Volume In Three Month959.82k
Date Short Interest15th of December 2021

Odonate Therapeutics Technical Analysis

Odonate Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Odonate Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Odonate Therapeutics. In general, you should focus on analyzing Odonate Stock price patterns and their correlations with different microeconomic environments and drivers.

Odonate Therapeutics Predictive Forecast Models

Odonate Therapeutics' time-series forecasting models is one of many Odonate Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Odonate Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Odonate Therapeutics

Checking the ongoing alerts about Odonate Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Odonate Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Odonate Therapeutics is not yet fully synchronised with the market data
Odonate Therapeutics has some characteristics of a very speculative penny stock
Odonate Therapeutics has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (102.07 M).
Odonate Therapeutics has about 95.03 M in cash with (94.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Roughly 66.0% of the company shares are owned by institutional investors
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Odonate Therapeutics information on this page should be used as a complementary analysis to other Odonate Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Odonate Stock

If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios